The Priority Review

Tag

Genomics

1 story

Stories

  1. Policy

    Genomics announces extension of strategic drug discovery collaboration with Vertex

    Genomics announced a four-year extension of its eight-year drug target discovery and validation collaboration with Vertex, beginning November 18, 2026. The total potential contract value exceeds $220 million for milestone achievements and future royalties.